What is Joshua Attias's NPI number?

Joshua Attias's National Provider Identifier (NPI) is 1467124982, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Joshua Attias's specialty?

Joshua Attias is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Joshua Attias located?

Joshua Attias's practice location on file with NPPES is 1333 3rd Ave S Ste 501, Naples, FL 34102-6538.

What is Joshua Attias's phone number?

The practice phone number listed in the NPPES registry for Joshua Attias is (239) 300-9767.

Does Joshua Attias accept Medicare?

Joshua Attias is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Joshua Attias's NPI active?

Yes — Joshua Attias's NPI (1467124982) is active in the NPPES registry as of the last update on 2021-10-03.

IndividualActiveAccepts Medicare

Joshua Attias, PA-C

NPI 1467124982 · Dermatology Physician · Naples, FL

Joshua Attias, PA-C is a Dermatology Physician provider in Naples, FL (NPI 1467124982).

Provider details

NPI number: 1467124982
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: PA-C
Sex: Male
Sole proprietor: No
License: 9115005 (FL)

Practice location

1333 3rd Ave S Ste 501

Naples, FL 34102-6538

Phone: (239) 300-9767

Street-level locationGet directions

More FL providers

Mailing address

1333 3rd Ave S Ste 501

Naples, FL 34102

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 9115005 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(62/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
5 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,301 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,158	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	523	$78
Destruction of Precancer Skin Growth, 1 Growth17000	392	$38
Biopsy of Related Skin Growth, First Growth11102	301	$74
Destruction of Skin Growth, 1-14 Growths17110	205	$94
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	216	111
Clobetasol Propionate	117	67
Triamcinolone Acetonide	116	94
Minoxidil	70	29
Mupirocin	68	57
Doxycycline Hyclate	45	35
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	41	34
Fluocinonide	41

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,700 across 64 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2021-10-03
Last updated: 2021-10-03
Certified: 2021-10-01

Frequently asked questions

What is Joshua Attias's NPI number?: Joshua Attias's National Provider Identifier (NPI) is 1467124982, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Joshua Attias's specialty?: Joshua Attias is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Joshua Attias located?: Joshua Attias's practice location on file with NPPES is 1333 3rd Ave S Ste 501, Naples, FL 34102-6538.
What is Joshua Attias's phone number?: The practice phone number listed in the NPPES registry for Joshua Attias is (239) 300-9767.
Does Joshua Attias accept Medicare?: Joshua Attias is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Joshua Attias's NPI active?: Yes — Joshua Attias's NPI (1467124982) is active in the NPPES registry as of the last update on 2021-10-03.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,158	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	523	$78
Destruction of Precancer Skin Growth, 1 Growth17000	392	$38
Biopsy of Related Skin Growth, First Growth11102	301	$74
Destruction of Skin Growth, 1-14 Growths17110	205	$94
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	216	111
Clobetasol Propionate	117	67
Triamcinolone Acetonide	116	94
Minoxidil	70	29
Mupirocin	68	57
Doxycycline Hyclate	45	35
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	41	34
Fluocinonide	41

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,700 across 64 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments